El bicarbonato quizá no beneficie a todos los pacientes con acidosis metabólica. Tras SODa-BIC, la pregunta ya no es si funciona, sino ¿en qué pacientes podría seguir aportando beneficio?
Revisa el resumen visual creado por Daniel Ramirez #NephJC
This week, we will discuss the best schedule for tapering steroids in adult patients with podocytopathies (MCD/FSGS).
This week, we will discuss the use of LLMs for the diagnosis of complex nephrology cases. Can AI help nephrologists nail the correct diagnosis?
MERCURI-2 reports that dapagliflozin cuts postoperative AKI after cardiac surgery, but the headline result is mostly a urine-output story, not a creatinine one. That matters: urine output after surgery is easily swayed by anesthesia, fluid shifts, vasopressors, and a diuretic drug in the mix. Until dapagliflozin shows it protects kidney function, not just urine output.
El bicarbonato quizá no beneficie a todos los pacientes con acidosis metabólica. Tras SODa-BIC, la pregunta ya no es si funciona, sino ¿en qué pacientes podría seguir aportando beneficio?
Revisa el resumen visual creado por Daniel Ramirez #NephJC
Bicarbonate may not benefit all patients with metabolic acidosis. After SODa-BIC, the question is no longer whether it works, but which patients, might still benefit.
Check out the VA by Daniel Ramirez #NephJC
RCT of PO sodium bicarbonate in patients with renal transplant to see if impacts stability of renal function - catch up here!
Welcome to #TenTweetNephJC
— Nephrology Journal Club (@NephJC) June 16, 2023
We bring to you today a treatment suggested (2B) by KDIGO to be beneficial in slowing eGFR decline of non-Transplant patients, and evaluate its evidence in the Tx cohort.
Does NaHCO3 Preserve-Transplant function? 🧵
✳️ 10 tweets #NephJC catch-up ✳️ pic.twitter.com/vSgmerzo2o
Another home run, from Divya Bajpai